Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724687 | SCV000225389 | uncertain significance | not provided | 2015-03-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724687 | SCV000241710 | likely benign | not provided | 2021-06-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000702921 | SCV000831798 | uncertain significance | Intellectual disability, autosomal dominant 1 | 2024-01-25 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 968 of the MBD5 protein (p.Ser968Leu). This variant is present in population databases (rs200985982, gnomAD 0.05%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with MBD5-related conditions. ClinVar contains an entry for this variant (Variation ID: 193912). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MBD5 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV000724687 | SCV001714001 | uncertain significance | not provided | 2019-06-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000724687 | SCV004154084 | uncertain significance | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing |